InvestorsHub Logo

rosemountbomber

07/23/22 6:53 PM

#384162 RE: lizzy241 #384159

Only to healthcare practitioners and it is in effect now.

Maybe they should send a rep to Nissen's office to clue him in.

HDGabor

07/24/22 5:39 AM

#384173 RE: lizzy241 #384159

l-

doesn't that include marketing to the public as well as prescribers

Definitely not....

District Court has ruled that Amarin may promote to healthcare professionals certain uses of Amarin's lead product, Vascepa®(icosapent ethyl) capsules, that are not covered by current FDA-approved labeling for the drug so long as the promotion is truthful and non-misleading.

Best,
G